Поиск
Озвучить текст Озвучить книгу
Изменить режим чтения
Изменить размер шрифта
Оглавление
Для озвучивания и цитирования книги перейдите в режим постраничного просмотра.

Список литературы

  1. Международная классификация болезней 10-го пересмотра. 1995. с. 685-686
  2. Hernlund E, Svedbom A., Ivergard M. et al. Osteoporosis in the Europian Union: medical management, epidemiology and economic burden. Arch Osteoporos.2013. 8. (1-2): 136. DOI: 10.1007/s11657-013-0136-1
  3. Родионова С.С., Макаров М.А., Колондаев А.Ф. Значение минеральной плотности и показатели качества костной ткани в обеспечении её прочности при остеопорозе. Вестник травматологии и ортопедии. 2001, 2: 76-80.
  4. Holzer G., von Skrbensky G, Holzer LA, Pichl W. Hip fractures and the contribution of cortical versus trabecular bone to femoral neck strength. J Bone Miner Res. 2009. Mar 24(3):468- 74. DOI: 10.1359/jbmr.081108
  5. Palvanen M, Kannus P, Niemi S, Parkkari J. Update in the epidemiology of proximal humeral fractures. Clin Orthop Relat Res. 2006. Jan; 442:87-92.
  6. Huopio J, Kroger H, Honkanen R, Saarikoski S, Alahava E. Risk factors for perimenopausal fractures: a prospective study. Osteoporos Int. 2000 11:219–27. DOI: 10.1007/s001980050284
  7. Lin J, Hou S-M, Hang Y-S. Locked nailing for displaced surgical neck fractures of the humerus. J Trauma.1998. 45:1051–7.
  8. Astrand J, Thorngren KG, Tagil M. One fracture is enough! Experience with a prospective and consecutive osteoporosis screening program with 239 fracture patients Acta Orthop. 2006. 77:3–8. DOI: 10.1080/17453670610045623
  9. Robinson CM. Proximal humerus fractures Fractures in adults. Philadelphia: Lippincott Williams & Wilkins 2010. 1039–105. DOI 10.1007/978-3-319-08951-5
  10. Chu SP, Kelsey JL, Keegan TH, et al. Risk factors for proximal humerus fracture. Am J Epidemiol. 2004. 160:360–7. DOI: 10.1093/aje/kwh224
  11. Olsson C, Petersson CJ. Clinical importance of comorbidity in patients with a proximal humerus fracture. Clin Orthop Relat Res. 2006 442:93–9.
  12. Schwartz AV, Nevitt MC, Brown Jr BW, Delsey JL Increased falling as a risk factor for fracture among older women: the study of osteoporotic fractures. Am. J Epidemiol. 2005. 161:180–5. DOI: 10.1093/aje/kwi023
  13. Johnell O., Kanis J.A. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006. Dec; 17(12):1726-33. DOI https://doi: org/10.1007/s00198-006-0172-4 
  14. Icks A, Haastert B, Wildner M, Becker C, Meyer G.Trend of hip fracture incidence in Germany 1995-2004: a population-based study. Osteoporos Int. 2008. Aug; 19 (8):1139-45. DOI https://doi.org/10.1007/s00198-007-0534-6
  15. Kanis J. Assessment of osteoporosis at the primary health-care level. Summary Report of a WHO.Centre for Metabolic Bone Diseases, University of Sheffield; UK: 2007. 13-52/
  16. Singer A., Exuzides A., Spangler L. et al. Burden of illness for osteoporotic fractures compared with other serious diseases among postmenopausal women in the United States. Mayo Clin Proc. 2015 Jan: 90 (1):53-62. DOI: https://doi.org/10.1016/j.mayocp.2014.09.011
  17. Гладкова Е. Н., Лесняк О.М., Безлюдная Н В. с соавт. Тяжелый остеопороз у мужчин в Российской Федерации (исследование ОСТЕО-РФ). Остеопороз и остеопатия. 2020; vol. 23(1):74-75.
  18. Cooper C, Campion G, Melton L J 3 rd. Hip fractures in the elderly: a world-wide projection. Osteoporos Int. 1992 Nov;2(6):285-9.
  19. Gullberg B., Johnell O., Kanis J.A. World-wide projections for hip fracture. Osteoporos. Int. 1997; 7 (5): 407-13.
  20. Burge R., Dawson-Hughes B., Solomon D.H. et al. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. J Bone Miner Res. 2007. 22(3): 465–475. https://DOI:org/10.1359/jbmr.061113
  21. Leslie W.D., Morin S.N. Osteoporosis epidemiology 2013: implications for diagnosis, risk assessment, and treatment. Current opinion in rheumatology. 2014. 26(4):440–6. DOI:10.1302/0301-620X/94B7.28693/
  22. Лесняк О.М. Ершова О.Б., Беловыа К.Ю., Гладкова Е.Н., Синицина О.С. с соавт Эпидемиология остеопоротических переломов в Российской Федерации и Российская модель FRAX.Остеопороз и остеопатии 2014, №3. 3-9.
  23. Lauritzen JB, Schwarz P, Lund B, McNair P, Transbol I. Changing incidence and residual lifetime risk of common osteoporosis-related fractures. Osteoporos Int. 1993. 3:127– 32.
  24. Kristiansen B, Barfod G, Bredesen J, et al. Epidemiology of proximal humeral fractures. Acta Orthop Scand. 1987. 58:75–7
  25. Kannus P, PalvanenM, Niemi, S, Parkkari J, Jarvienen M, Vuori I. Increasing number and incidence of osteoporotic fractures of the proximal humerus in elderly people. BMJ.1996 313(7064):1051–2.
  26. Court-Brown CM, Caesar B. Epidemiology of adult fractures: a review. Injury 2006.37: 691–7. DOI: 10.1016/j.injury.2006.04.130
  27. Кривова А.В., Тимаев Р.В., Родионова С.С. Эпидемиология переломов проксимального отдела бедра в популяции города Твери. Вестник травматологии и ортопедии им. Н.Н. Приорова, 2006, 2 (апрель-июнь),17-20.
  28. Оноприенко Г.А., Древаль А.В., Марченкова Л.А., Крюкова И.В. Ретроспективный анализ частоты и стоимости лечения переломов проксимального отдела бедра и дистального отдела предплечья в Московской области (1998-2002). Вестник травматологии и ортопедии им. Н.Н. Приорова, 2006,2 (апрель-июнь), 10-16.
  29. Sabesan VJ, Valikodath T, Childs A, Sharma VK. Economic and social impact of upper extremity fragility fractures in elderly patients. Aging Clin Exp Res. 2015 Aug; 27(4):539-46. DOI: 10.1007/s40520-014-0295-y
  30. Лебедева А.К., Лесняк О.М., Галстян Р, Елисеева Л.Н., Епанов В.В. с соавт Эпидемиология переломов предплечья, плеча и голени у населения 50 лет и старше в Росссии, Армении, Молдове и Узбекистане (исследование ЭВА) Остеопороз и остеопатии 2016, №2. 16 с.
  31. Freedman KB, Kaplan FS, Bilker WB, Strom BL, Lowe RA. Treatment of osteoporosis: are physicians missing an opportunity? J Bone Joint Surg Am. 2000. 82 A: 1063– 1070.
  32. Talbot JC, Elener C, Praveen P, Shaw DL. Secondary prevention of osteoporosis: Calcium, Vitamin D and bisphosphonate prescribing following distal radial fracture. Injury. 2007. 38: 1236–1240. DOI: 10.1016/j.injury.2007.03.004
  33. Foroohar A, Tosti R, Richmond JM, Gaughan JP, Ilyas AM. Classification and treatment of proximal humerus fractures: inter-observer reliability and agreement across imaging modalities and experience J Orthop. Surg. Res 2011. 6:38. DOI: 10.1186/1749-799X-6-38
  34. Young TB, Wallace WA. Conservative treatment of fractures and fracture-dislocations of the upper end of the humerus. J Bone Joint Surg Br.1985. 67 B: 373–7.
  35. Мюллер М.Е., Альговер М., Шнайдер Р., Виллингер Х.// Руководство по внутреннему остеосинтезу. Springer-Verlag. – 1996., - 750 с.
  36. Neer II CS. Displaced proximal humeral fractures. I. Classification and evaluation. J Bone Joint Surg Am 1970.52:1077–89.
  37. De Franco MJ, Brems JJ, Williams Jr GR, Iannotti JP. Evaluation and management of valgus impacted four-part proximal humerus fractures. Clin Orthop Relat Res. 2006 442:109–14.
  38. Khatib O, Onyekwelu I, Zuckerman JD. The incidence of proximal humeral fractures in New York State from 1990 through 2010 with an emphasis on operative management in patients aged 65 years or older. J Shoulder Elbow Surg. 2014. Sep., 23 (9):1356-62. DOI: 10.1016/j.jse.2013.12.034 
  39. Genant H, Wu C, van Kuijk C, Nevitt M. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res. 2009;8(9):1137-1148. doi:10.1002/jbmr.5650080915.
  40. American Academy of Orthopedic Surgeons (AAOS). American Academy of Orthopedic Surgeons clinical practice guideline on: the treatment of distal radius fractures. J Bone Joint Surg. Am. 2011. Apr 20:93(8):775-8. DOI: 10.2106/JBJS.938ebo
  41. Ralph Hertel. Fractures of the proximal humerus in osteoporotic bone. Osteoporos Int (2005) 16: S65–S72DOI 10.1007/s00198-004-1714-2
  42. Green A., Norris T. Proximal humerus fractures and fracture dislocations. In: Browner B, Jupiter J, Levine A, Trafton P, editors. Skeletal trauma: basic science, management and reconstruction. 3. Philadelphia: Saunders; 2003. pp. 1532–1624
  43. Delmas PD, van de Langerijt L, Watts NB et al. Underdiagnosis of vertebral fractures is a worldwide problem: the IMPACT study. J Bone Miner Res. 2005 Apr;20(4):557-63. Epub 2004 Dec 6 10.1359/JBMR.041214
  44. Watts NB, Adler RA, Bilezikian JP, et al. Osteoporosis in men: an Endocrine Society clinical practice guideline. J Clin. Endocrinol. Metab. 2012. 97 (6):1802–1822. DOI: 10.1210/jc.2011-3045
  45. Cosman F, de Beur S, Le Boff M, de Beur SJ, Tanner B Clinician’s Guide to Prevention and Treatment of Osteoporosis. Osteoporos Int. 2014 Oct;25(10):2359-81. doi: 10.1007/s00198- 014-2794-2. Epub 2014 Aug 15.
  46. Schousboe J, Ensrud K, Nyman J, Kane R, Melton L. Potential cost-effective use of spine radiographs to detect vertebral deformity and select osteopenia post-menopausal women for amino-bisphosphonate therapy. Osteoporosis International. 2005: 16 (12):1883-1893.
  47. Jimenez-Andrade JM, Mantyh WG, Bloom AP, Freeman KT, Ghilardi JR, Kuskowski MA, Mantyh PW. The effect of aging on the density of the sensory nerve fiber innervation of bone and acute skeletal pain. Neurobiol Aging. 2010. 33: 921–932. DOI: 10.1016/j.neurobiolaging.2010.08.008
  48. Wu SS, Lachmann E, Nagler W. Current medical, rehabilitation, and surgical management of vertebral compression fractures. J Womens Health (Larchmt) 2003. Jan-Feb: 12(1):17–26. DOI: 10.1089/154099903321154103
  49. Sinaki M, Pfeifer M, Preisinger E, et al. The role of exercise in the treatment of osteoporosis. Curr Osteoporos Rep. 2010. 8(3):138–144. DOI: 10.1007/s11914-010-0019-y
  50. Gasik R, Styczy ski T. Specifics of pharmacological treatment of back pains in people of old age. Polski Merkuliusz Lekarski. 2006. (124):394–397
  51. Bianchi M, Orsini M, Saraifoger S. et.al. Quality of life in post-menopausal osteoporosis. Health Qua! Life Outcome. 2005; 3-78. DOI: 10.1186/1477-7525-3-78
  52. Francis RM, Aspray TJ, Hide G, et al. Back pain in osteoporotic vertebral fractures Osteoporos Int. 2008. 19: 895–903. DOI: 10.1007/s00198-007-0530-x
  53. Родионова С.С., Хакимов У. Р. Безопасность долгосрочного использования альфакальцидола при первичных формах системного остеопороза у мужчин. Клиническая геронтология. 2016. 5: 26-33.
  54. O Sahota , M K Mundey, P San, et al The relationship between vitamin D and parathyroid hormone: calcium homeostasis, bone turnover, and bone mineral density in postmenopausal women with established osteoporosis.2004 Jul;35(1):312-9. doi: 10.1016/j.bone.2004.02.003.
  55. Johansson H, Oden A, Kanis JA, McCloskey EV, Morris HA, Cooper C, Vasikaran (2014) A meta-analysis of reference markers of bone turnover for prediction of fracture. Calcif Tissue Int 94:560–567
  56. Tannenbaum C, Clark J, Schwartzman K, Wallenstein S, Lapinski R, Meier D, et al. Yield of laboratory testing to identify secondary contributors to osteoporosis in otherwise healthy women. J Clin Endocrinol Metab. 2002;87: 4431-4437 41
  57. Garnero P., Sornay-Rendu E., Claustrat B., et al. Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study. J Bone Miner. Res. 2000. 15(8):1526–1536. DOI: 10.1359/jbmr.2000.15.8.1526
  58. Родионова С.С., Буклемишев Ю.В. Эффективность золедроновой кислоты у пациентов с системным остеопорозом и проблема «неответчиков» на лечение. Вестник травматологии и ортопедии. 2015. №4. 39-43.
  59. Glendenninga Р., Chubba Р., Vasikarana S. Clinical utility of bone turnover markers in the management of common metabolic bone diseases in adults. Clinica Chimica Acta 481 (2018) 161–170.DOI.org/10.1016/jcca2018.03.009
  60. Borghi L., Schianchi T., Meschi T., et. al. Comparison of Two Diets for the Prevention of Recurrent Stones in Idiopathic Hypercalciuria.. N Engl. J Med. 2002.346:77-84. DOI: 10.1056/NEJMoa010369
  61. Ермакова И.П., Пронченко И.А., Бузулина В.П, Родионова С.С., Оганов В.С. Диагностическая значимость биохимических маркеров резорбции и формирования костной ткани у женщин с постменопаузальным остеопорозом. Остеопороз и остеопатии 1998. 2.10- 12.
  62. Wei Zhang , Guo-Ji Yang, Shi-Xian Wu, Dong-Qing Li, Ying-Bo Xu, et.al. The guiding role of bone metabolismtest in osteoporosis treatment (Review Article) J Clin Exp Immunol 2018;7(2):40-49
  63. Am Mohamed Y, Haifa H, Datel O, Fadoua HN,Smeh BH, Mahbouba J, Saoussen Z, Bejia I, Mongi T, Mohamed FN and Naceur B. The role of biochemical markers of bone turnover in the diagnosis of osteoporosis and predicting fracture risk. Tunis Med 2014; 92: 304-310.
  64. Burch J., Rice S., Yang H., et al. Systematic review of the use of bone turnover markers for monitoring the response to osteoporosis treatment: the secondary prevention of fractures, and primary prevention of fractures in high-risk groups. Health Technology Assessment. 2014. 18 (11): 1-180. DOI: 10.3310/hta18110
  65. Spinnato P, Bazzocchi A, Facchini G et al. Vertebral Fractures of Unknown Origin: Role of Computed Tomography-Guided Biopsy. Int J Spine Surg. 2018 Dec 21;12(6):673-679. doi: 10.14444/5084. eCollection 2018 Dec.
  66. Ivata T, Nozawa S, Dohjima T, Yamamoto T et. al. The value of TI–weighted coronal MRT scans in diagnosing occult fracture of the hip. 2012. 94(7): 969-973. DOI:10.1302/0301- 620X.94B7.28693.
  67. Lobo MJ, Levine WN. Classification and closed treatment of proximal humerus fractures. In: Wirth MA, editor. Proximal humerus fractures. Chicago: American Academy of Orthopaedic Surgeons 2005. 1–13. DOI 10.1007/978-3-319-08951-5
  68. Hartsock LA, Estes WJ, Murray CA, Friedman RJ. Shoulder hemiarthroplasty for proximal humeral fractures. Orthop. Clin/ North Am 1998. 29 (3): 467–75.
  69. Jurik AG, Albrechtsen J. The use of computed tomography with two- and three- dimensional reconstructions in the diagnosis of three- and fourpare fractures of the proximal humerus. Clin Radiol 1994 49: 800–4.
  70. Bohsali KI, Wirth MA Fractures of the proximal humerus. The shoulder. 4 th ed. Philadelphia: Saunders Elsevier. 2009. 295–332.
  71. Kendall CB, Tanner SL, Tolan SJ. SLAP tear associated with a minimally displaced proximal humerus fracture. Arthroscopy. 2007. 23 (12):1362 e1–3. DOI: 10.1016/j.arthro.2006.08.010
  72. Kazawa N. T2WI MRI and MRI-MDCT correlations of the osteoporotic vertebral compressive fractures. European Journal of Radiology. 2012. 81(7):1630-1636. DOI: 10.1016/j.ejrad.2011.04.052
  73. Lafontaine M, Hardy D, Delince P. Stability assessment of distal radius fractures. Injury. 1989. Jul. 20(4): 208-10.
  74. Schuind F, Cooney W, Linscheid R, An K, Chao E. Force and pressure transmission through the normal wrist. A theoretical two-dimensional study in the posteroanterior plane. J Biomech. 1995. May. 28 (5):587-601.
  75. Kanis J, McCloskey E, Johansson H, Cooper C, Rizzoli R, Reginster J. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporosis International.2013. 24(1):23-57. DOI: 10.1007/s00198-012-2074-y
  76. Camacho PM, Petak SM, Binkley N, Clarke BL, Harris ST et.al. Postmenopausal Osteoporosis Guidelines, Endocr Pract. 2020;26(Suppl 1) 46 р
  77. Клинические рекомендации Остеопороз. ID: 87. 2021. URL: https://cr.minzdrav.gov.ru/recomend/87_4
  78. Official Positions of the International Society for Clinical Densitometry Copyright ISCD. October 2007.
  79. Lems W F Dreinhöfer, K E Bischoff-Ferrari H, Blauth M, et,al EULAR/EFORT recommendations for management of patients older than 50 years with a fragility fracture and prevention of subsequent fractures ARD Online First, published on December 22, 2016 as 10.1136/annrheumdis-2016-210289.
  80. Родионова С.С., Нуждин В.И., Морорзов А.К, Клюшничненко с соавт.. Остеопороз как фактор риска асептической нестабильности при эндопрпотезировании тазобедренного сустава. Вестник травматологии и ортопедии им. Н.Н.Приорова.2007 №2 апрель-июнь. 35-40
  81. Родионова С.С., Лазарев А.Ф., Колондаев А.Ф., Солод Э.И. Комбинированное лечение переломов шейки бедренной кости на фоне остеопороза. Медицинская технологи.2007.С. 1-15. Москва
  82. Viprey Marie, Caillet Pascal, Canat Guillaume, Jagla Susan, Haesebaert Julie, Chapurlat, Roland, Schott Anne-Marie. Relate Low Osteoporosis Treatment Initiation Rate in Women after Distal Forearm or Proximal Humerus Fracture: A Healthcare Database Nested Cohort Study Published. PLoS One. 2015 Dec 2;10 (12):e 0143842. doi: 10.1371/journal.pone.0143842. eCollection 2015.
  83. Родионова С.С., Колондаев А.Ф., Соколов В.А. Марков С.А. Сергеев С.В. Результаты использования препарата Остеогенон у пациентов с различной патологией опорно-двигательного аппарата Остеопороз и остеопатии. -1999. -№43-46
  84. Гюльназарова С.В., Кузнецова О.А. Оссеин-гидроксиапатитный комплекс в лечении больных с пседоартрозами бедра и костей голени, осложненными системным остеопорозом // Вестн. травматологии и ортопедии им.Н.Н.Приорова. – 2006. – № 2. – С.21- 24. 
  85. Kyvernitakis I, Kostev K, Kurth A, Albert US, Hadji P. Differences in persistency with teriparatide in patients with osteoporosis according to -gender and health care provider. Osteoporos Int. 2014, Dec; 25. (12):2721-8. DOI: 10.1007/s00198-014-2810-6
  86. The DIPART Group. Patient level pooled analysis of 68500 patients from seven major vitamin D fracture prevention in US and Europe. BMJ. 2010;340 :b546Bischoff-.
  87. Doetsch AM, Faber J, Lynnerup N, et al. The effect of calcium and vitamin D3 supplementation on the healing of the proximal humerus fracture: a randomized placebo controlled study. Calcif Tissue Int 2004 75:183–8. DOI: 10.1007/s00223-004-0167-0
  88. Nuti R., Bianchi G., Brandi M.L., et al. Superiority of alfacalcidol compared to vitamin D plus calcium in lumbar bone mineral density in postmenopausal osteoporosis. Rheumatol. Int. 2006 Mar;26 (5):445-53.. DOI: 10.1007/s00296-005-0073-4
  89. Оглоблин Н.А., Спиричев В.Б., Батурин А.К. О потреблении населением России кальция с пищей. Вопросы питания. -М.-2005. 5: 14-17.
  90. Varenna M., Binelli L., Casari S., et al. Effects of dietary calcium intake on body weight and prevalence of osteoporosis in early postmenopausal women. Am J Clin. Nutr. 2007. Sep; 86(3):639-44.
  91. Heaney R.P. Quantifying human calcium absorption using pharmacokinetic methods. J Nutr.. 2003. Apr 133. (4):1224-6.
  92. Buclin T., Jacquet A.F., Burckhardt P. Intestinal absorption of calcium gluconate and oseine-mineral complex: an evaluation by conventional analyses. Schweiz Med. Wochenschrift. 1986 Dec 13;116 (50):1780-3.
  93. Fernandez-Pareja A, Hernandez-Blanco E, Perez-Maceda J, et al. Prevention of osteoporosis, four year follow-up of a cohort of postmenopausal women treated with an ossein- hydroxyapatite compound. Clin. Drug Invest 2007. 27: 227-232.
  94. Castelo-Branco C., et al. Efficacy of ossein-hydroxyapatit complex compared with calcium carbonate to prevent bone loss: a meta-analysis. Menopause: The Journal of the North American Menopause Society 2009; 5: 84-991
  95. Annefeld M., Caviezel R., Schacht E., Schicketanz K.H. The influence of ossein- hydroxyapatite compound ('Ossopan') on the healing of a bone defect. Curr. Med. Res. Opin. 1986. 10 (4):241-50. DOI: 10.1185/03007998609110445
  96. Ciria-Recasens M, Blanch-Rubió J, Coll-Batet M et. al. Comparison of the effects of ossein-hydroxyapatite complex and calcium carbonate on bone metabolism in women with senile osteoporosis: a randomized, open-label, parallel group, controlled, prospective study. Clin Drug Investig. 2011. Dec 1; 31(12):817-24. DOI: 10.2165/11592930-000000000-00000
  97. Prentice R.L., Pettinger M.B., Jackson R.D., et al. Health risks and benefits from calcium and vitamin D supplementation: Women's Health Initiative clinical trial and cohort study. Osteoporosis Int. 2013 Feb; 24(2):567-80. DOI: 10.1007/s00198-012-2224-2
  98. Michaëlsson K., Melhus H., Warensjo Lemming E., et al. Long term calcium intake and rates of all cause and cardiovascular mortality: community based prospective longitudinal cohort study. BMJ. 2013 Feb 12; 346:f228. DOI: 10.1136/bmj.f228.
  99. Wacker M., Holick M.F. Sunlight and Vitamin D: A global perspective for health. Dermatoendocrinol. 2013 Jan 1;5(1):51-108. DOI: 10.4161/derm.24494
  100. Lau K.H., Baylink D.J. Vitamin D therapy of osteoporosis: plain vitamin D therapy versus active vitamin D analog (D-hormone) therapy. Calcif. Tissue Int. 1999 Oct; 65(4):295-306.
  101. Родионова С.С.Еловой-Вронский А. А.Бернакевич А.И. #альфакальцидол или колекальциферол в комбинации с ибандроновой кислотой при лечении постменопаузального системного остеопороза- Жур. Остеопороз и остеопатии 2014 №121- 24
  102. Francis RM. Is there a differential response to alfacalcidol and vitamin D in the treatment of osteoporosis? Calciff Tissue Int.1997/Jan.60 (1).111-4
  103. Yamato H, Okazaki R, Ishii T, Ogata E, Sato T, Kumegawa M, Akaogi K, Taniguchi N, Matsumoto T. Effect of 24R, 25-dihydroxyvitamin D3 on the formation and function of osteoclastic cells. Calcif Tissue Int 1993; 52:255-260.
  104. Rix M., Eskildsen P., Olgaard K. Effect of 18 months of treatment with alfacalcidol on bone in patients with mild to moderate chronic renal failure. Nephrol. Dial Transplant. 2004. 19:870-6. DOI: 10.1093/ndt/gfg595
  105. Sakhaee K., Maalouf N., Kumar R., et al. Nephrolithiasis-associated bone disease: pathogenesis and treatment options. Kidney Int.. 2011 Feb;79(4):393-403. DOI: 10.1038/ki.2010.473.
  106. Шварц Г.Я. Фармакотерапия остеопороза. Медицинское информационное агентство. Москва. 2002. c. 409.
  107. Родионова С.С. с соавт. Способ профилактики потери костной ткани вокруг имплантантов при эндопротезировании. Патент РФ на изобретение №2176519 от 10.12.01
  108. Hallan G., Lie S.A., Havelin L.I. High wear rates and extensive osteolysis in 3 types of uncemented total hip arthroplasty: a review of the PCA, the Harris Galante and the Profile/Tri- Lock Plus arthroplasties with a minimum of 12 years median follow-up in 96 hips. Acta Orthop. 2006. Aug. 77(4): 575-584. DOI: 10.1080/17453670610012638 
  109. Colon-Emeric C., Nordsletten L., Olson S., et al. Association between timing of zoledronic acid infusion and hip fracture healing. Osteoporos. Int. 2011 Aug;22(8):2329-36. doi: 10.1007/s00198-010-1473-1.
  110. Kendler D., Roux C., Benhamou C, Brown J et al. Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy. J Bone Miner Res. 2010 Jan;25(1):72-81. doi: 10.1359/jbmr.090716.
  111. Mandema J.W., Zheng J., Libanati C., et al. Time course of bone mineral density changes with denosumab compared with other drugs in postmenopausal osteoporosis: a dose- response-based meta-analysis. J Clin. Endoc. Meta. 2014 Oct;99(10):3746-55. doi: 10.1210/jc.2013-3795.
  112. Poole KE1, Treece GM, Gee AH, Brown JP, McClung MR, Wang A, Libanati C. Denosumab rapidly increases cortical bone in key locations of the femur: a 3D bone mapping study in women with osteoporosis. J Bone Miner Res 2015 Jan;30(1):46-54. doi: 10.1002/jbmr.2325.
  113. Zebaze R, Libanati C, McClung MR, Zanchetta JR et.al. Denosumab Reduces Cortical Porosity of the Proximal Femoral Shaft in Postmenopausal Women With Osteoporosis. J Bonе Miner Res 2016 Oct;31(10):1827-1834. doi: 10.1002/jbmr.2855. Epub 2016 May 19.
  114. Nishioka T. Yagi S, Mitsuhashi T et.al. Alendronate inhibits periprosthetic bone loss around uncemented femoral components. J Bone Miner. Metab. 2007. 25:179–183. DOI: 10.1007/s00774-006-0743-7
  115. Родионова С.С.Тургунбаев Т.Н. Применение алендроната в послеоперационном периоде для профилактики асептической нестабильности эндопротеза тазобедренного сустава. Вестник травматологии и ортопедии им. Н.Н.Приорова. 2009№3 36-44
  116. Kim S.C., Gimeno G.S., Kim M.S., et al. Use of Osteoporosis Medications after Hospitalization for Hip Fracture: A Crossnational Study. Am. J Med. 2015 May; 128(5):519-26e1. doi: 10.1016/j.amjmed.2015.01.014.
  117. Solomon D.H., Johnston S.S., Boytsov N.N., et al. Osteoporosis medication use after hip fracture in U.S. patients between 2002 and 2011.J Bone Miner Res. 2014;29:1929-1937. DOI: 10.1002/jbmr.2202
  118. Bhadata S., Sridhar S., Muthukrishnan J., Mithal A., Sarma D, et. A.l Predictors of atypical femoral fractures during longterm bisphosphonate therapy: a case series (review of literature). J.Med. Res. 2014 Iul. 140(1): 46-54.
  119. Durie B.G., Katz M., Crowley J. Osteonecrosis of the jaw and bisphosphonates. N Engl J Med. 2005 Jul 7;353(1):99-102. DOI: 10.1056/NEJM200507073530120
  120. Gedmintas L., Solomon D.H., Kim S.C. Bisphosphonates and risk of subtrochanteric, femoral shaft, and atypical femur fracture: a systematic review and meta-analysis. J Bone Miner Res. 2013 Aug;28(8):1729-37. doi: 10.1002/jbmr.1893.
  121. Dixon W.G., Solomon D.H. Bisphosphonates and esophageal cancer—a pathway through the confusion. Nat Rev Rheumatol. 2011 Jun;7(6):369-72. doi: 10.1038/nrrheum.2011.60.
  122. Grbic J.T., Landesberg R., Lin S.Q., et al. Incidence of osteonecrosis of the jaw in women with postmenopausal osteoporosis in the health outcomes and reduced incidence with zoledronic acid once yearly pivotal fracture trial. J Am Dent Assoc. 2008. 139. 1:32–40.
  123. Imaz I., Zegarra P., González-Enríquez J., et al. Poor bisphosphonate adherence for treatment of osteoporosis increases fracture risk: systematic review and meta-analysis. Osteoporosis Int. 2010 Nov;21(11):1943-51. doi: 10.1007/s00198-009-1134-4. 5.
  124. Schilcher J., Aspenberg P. Incidence of stress fractures of the femoral shaft in women treated with bisphosphonate. Acta Orthop. 2009 Aug;80(4):413-5. doi: 10.3109/17453670903139914.
  125. Lyles K.W., Colon-Emeric C.S., Magaziner J.S., et al. Zoledronic acid and clinical fracture and mortality after hip fracture. N Engl. J Med. 2007 Nov 1;357(18):1799-809. doi: 10.1056/NEJMoa074941.
  126. Cosman F., Cauley J., Eastell R., et al. Reassessment of fracture risk in women after 3 years of treatment with zoledronic acid: when is it reasonable to discontinue treatment. J. Clin. Endocrinol & Metabol. 2014 Dec;99 (12):4546-54. doi: 10.1210/jc.2014-1971.
  127. Amanat N., McDonald M., Godfrey C., et al. Optimal timing of a single dose of zoledronic acid to increase strength in rat fracture repair. J Bone Miner. Res. 2007. Jun ; 22(6):867–76. DOI: 10.1359/jbmr.070318
  128. Black D.M., Delmas P.D., Eastell R., et al. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med. 2007 May 3; 356(18):1809-22. DOI: 10.1056/NEJMoa067312
  129. Adami S, Libanati C., Boonen S., Cummings S. R, Ho PR, Wang A,et al. Denosumab treatment in postmenopausal women with osteoporosis does not interfere with fracture-healing: results from the FREEDOM trial. J Bone Joint Surg. Am. 2012 Dec 5; 94 (23):2113-9. DOI: 10.2106/JBJS.K.00774
  130. Choi NK, Solomon DH, Tsacogianis TN, Landon JE, Song HJ, Kim SC. Comparative safety and effectiveness of Denosumab versus Zoledronic acid in patients with osteoporosis: A cohort study. J Bone Miner Res. 2017 Mar;32(3):611-617. doi: 10.1002/jbmr.3019.
  131. Reid I.R. Denosumab after 8 years. Osteoporos Int. 2015 Dec;26(12):2759-61. doi: 10.1007/s00198-015-3347-z. 
  132. Massart F., Brandi M. Genetics of the bone response to bisphosphonate treatments. Clin. Cases Miner. Bone Metab. 2009, 6 (1)50-54.
  133. Oteo-Álvaro Á. Matas J.A., Alonso-Farto J.C. Teriparatide (rh [1-34] PTH) improved osteointegration of a hemiarthroplasty with signs of aseptic loosening. Orthopedics. 2011 Sep 9;34 (9):e574-7. doi: 10.3928/01477447-20110714-50.
  134. Huang T.W., Chuang P.Y., Lin S.J., et al. Teriparatide Improves Fracture Healing and Early Functional Recovery in Treatment of Osteoporotic Intertrochanteric Fractures. Medicine (Baltimore). 2016 May;95(19):e3626. doi: 10.1097/MD.0000000000003626.
  135. Huang T.W., Yang T.Y., Huang K.C., et al. Effect of Teriparatide on Unstable Pertrochanteric Fractures. Biomed. Res. Inter.Vol 2015(2015):568390. doi: 10.1155/2015/568390.
  136. Gagnon C., Li V., Ebeling P.R. Osteoporosis in men: its pathophysiology and the role of teriparatide in its treatment. Clin Interv Aging. 2008. Dec; 3(4): 635–645. .
  137. Bhandari M., Jin L., See K., et al. Does Teriparatide Improve Femoral Neck Fracture Healing: Results From A Randomized Placebo-controlled Trial. Clin Orthop Relat Res. 2016 May; 474(5):1234-44. doi: 10.1007/s11999-015-4669-z.
  138. Aspenberg P., Malouf J., Tarantino U, Carcia-Hernandez P et. al. Effects of Teriparatide Compared with Risedronate on Recovery After Pertrochanteric Hip Fracture Results of a Randomized, Active-Controlled, Double -Blind Clinical Trial at 26 Weeks. J Bone Joint Surg Am. 2016; 98:1868-78. DOI: 10.2106/JBJS.15.01217
  139. Eriksen E.F., Keaveny T.M., Gallagher E.R., et al. Literature review: The effects of teriparatide therapy at the hip in patients with osteoporosis. Bone. 2014 Oct;67:246-56. doi: 10.1016/j.bone.2014.07.014.
  140. Ivaska K.K., Gerdhem P., Akesson K., Garnero P., Obrant K.J. Effect of fracture on bone turnover markers: a longitudinal study comparing marker levels before and after injury in 113 elderly women. J Bone Miner Res. 2007; 22-8:1155–64.
  141. Tidermark J, Ponzer S, Carlsson P, Soderqvist A, Brismar K, et al. Effects of protein- rich supplementation and nandrolone in lean elderly women with femoral neck fractures. Clin. Nutr. 2004; 23:587–596. DOI: 10.1016/j.clnu.2003.10.006
  142. Avenell A, Handoll H. Nutritional supplementation for hip fracture after care in older people. Cochrane Database Syst. Rev. 2006 Oct 18;(4):CD001880. DOI: 10.1002/14651858.CD001880.pub4
  143. Leonardsson O, Rolfson O, Hommel A, Garellick G, Åkesson K, Rogmark C. Patient- Reported Outcome After Displaced Femoral Neck Fracture. J Bone Joint Surg Am. 2013 Sep 18; 95(18):1693-9. doi: 10.2106/JBJS.L.00836.
  144. Misra A, Kapur R, Maffulli N. Complex proximal humeral fractures in adults: a systematic review of management. Injury. 2001. 32:363–72.
  145. Handoll H, Gibson J, Madhok R. Interventions for treating proximal humeral fractures in adults. Cochrane Database Syst Rev. 2003;(4):CD000434. DOI: 10.1002/14651858.CD000434
  146. Lanting B, MacDermid J, Drosdowech D, Faber KJ. Proximal humeral fractures: a systematic review of treatment modalities. J Shoulder Elbow Surg.. 2008 Jan-Feb;17(1):42-54. doi: 10.1016/j.jse.2007.03.016
  147. Schmidt A. Proximal humeral fractures and shoulder dislocations. In: Stannard JP, Schmidt AH, Kregor PJ, editors. Surgical Treatment of Orthopaedic Trauma. New York: Thieme 2007. 238–62.
  148. Rasmussen S, Hvass I, Dalsgaard J, et al. Displaced proximal humeral fractures: results of conservative treatment. Injury. 1992. 23:41–3.
  149. Canale S. Terry, Campbell's James. Beaty Operative Orthopaedics Elsevier Health Sciences, 29 okt. 2012 .28-40
  150. Neviaser RJ, Resch H, Neviaser AS, Crosby LA Proximal humeral fractures. Instr Course Lect. 2015 64: 203-14.
  151. Antti P Launonen , Vesa Lepola, Tapio Flinkkilä, Niko Strandberg, et.al Conservative treatment, plate fixation, or prosthesis for proximal humeral fracture. A prospective randomized study. 2012. BMС Musculoskeletal Disorders. 2012,13(1):167 DOI: 10.1186/1471-2474-13-167
  152. Iannotti JP, Ramsey ML, Williams GR, et al. Nonprosthetic management of proximal humerus fractures. Instr Course Lect. 2004; 53:403-16.
  153. Jaberg H, Warner JJ, Jakob RP.Percutaneous stabilization of unstable fractures of the humerus. J Bone Joint Surg. Am. 1992 74:508–15.
  154. Koval KF, Gallagher MA, Marsicano JG, Cuomo F, McShinawy A, Zuckerman JD. Functional outcome after minimally displaced fractures of the proximal part of the humerus. J Bone Joint Surg Am. 1997 Feb79 (2):203-7.
  155. P, Larsen TK. Functional results following fractures of the proximal humerus. A controlled clinical study comparing two periods of immobilization Arch Orthop. Trauma Surg. 1989. 108 (6):339–41.
  156. Kleinlugtenbelt YV1, Bhandari M. Cochrane in CORR (®): Interventions for Treating Proximal Humeral Fractures in Adults (Review). Clin. Orthop. Relat. Res. 2015 Sep;473(9):2750- 6. doi: 10.1007/s11999-015-4430-7 
  157. Palvanen M, Kannus P, Parkkari J, et al. The injury mechanisms of osteoporotic upper extremity fractures among older adults: a controlled study of 287 consecutive patients and their 108 controls. Osteoporos. Int. 2000. 11(10):822-31.
  158. Leyshon RL. Closed treatment of fractures of the proximal humerus. Acta Orthop. Scand. 1984 55 (1):48–51.
  159. Clifford PC. Fractures of the neck of the humerus: a review of the late results. Injury. 1980 Sep;12(2):91-5.
  160. Hodgson S. Proximal humerus fracture rehabilitation. Clin. Orthop. Relat Res.. 2006 Jan ;442:131-8.
  161. Hanson B, Neibenbach P, de Boer P, Stengel D. Functional outcomes after nonoperative management of fractures of the proximal humerus. J Shoulder Elbow Surg. 2009 Jul- Aug;18(4):612-21. doi: 10.1016/j.jse.2009.03.024.
  162. Rommens P.M, Heyvaert G. Conservative treatment of subcapital humerus fractures Unfallchirurgie. 1993. 19 (2): 114–118.
  163. Xu-cheng Yang Zhen-han Deng Ting Wen Wei Luo Wen-feng Xiao Rui-bo Zhao Yu- sheng Li. Network Meta-Analysis of Pharmacological Agents for Osteoporosis Treatment and Fracture Prevention.Cell Physiol Biochem 2016;40:781-795 DOI: 10.1159/000453138 Published online: December 05, 2016
  164. Shenghan Lou, Houchen Lv, Guoqi Wang, Licheng Zhang, et.al.The Effect of Teriparatide on Fracture Healing of Osteoporotic Patients: A Meta-Analysis of Randomized Controlled Trials BioMed Research International 2016 "Volume 2016, Article ID 6040379, 10 pages. doi: 10.1155/2016/6040379.
  165. Solomon D., Hochberg, Mogun H, Schneeweiss. The relation between bisphosphonate use and non-union of fractures of the humerus in older adults. Osteoporosis Int. 2009 June. 20(6): 895–901. doi: 10.1007/s00198-008-0759-z
  166. Ensrud KE, Schousboe JT. Clinical practice. Vertebral fractures. N Eng. J Med 2011 Apr 28;364(17):1634-42. doi: 10.1056/NEJMcp1009697.
  167. Park Y, Kim H, Prevention and treatment of multiple osteoporotic compression fractures. Asian Spine J. 2014 Jun;8(3):382-90. doi: 10.4184/asj.2014.8.3.382.
  168. Longo UG, Loppini M, Denaro L, Maffulli N, Denaro V. Osteoporotic vertebral fractures: current concepts of conservative care. Br. Med Bull. 2012 Jun; 102:171-89. doi: 10.1093/bmb/ldr048.
  169. Barker K. L., Javaid M. K Newman M., Minns Lowe C. et.al. Physiotherapy rehabilitation for osteoporotic vertebral fracture (PROVE): study protocol for a randomised controlled trial. Trials 2014 Jan 14; 15:22. doi: 10.1186/1745-6215-15-22.
  170. Van Tulder M., Becker A., Bekkering T. et al. European guidelines for the management of acute nonspecific low back pain in primary care. Eur. Spine J. 2006 Mar; 15 Suppl 2:S169-91. doi:10.1007/s00586-006-1071-2.
  171. Pfeifer M, Begerow B, Minne HW. Effects of a new spinal orthosis on posture, trunk strength, and quality of life in women with postmenopausal osteoporosis: a randomized trial. Am J Phys. Med. Rehabil. 2004 Mar; 83 (3):177-86.
  172. Vellucci R, Mediati RD, Ballerini G. Use of opioids for treatment of osteoporotic pain. Clin Cases Miner Bone Metab. 2014. 11 (3):173–176.
  173. Huang LQ, He HC, He CQ, Chen J, Yang L. Clinical update of pulsed electromagnetic fields on osteoporosis. Chin Med J (Engl) 2008. Oct 20;121 (20):2095–2099.
  174. Kyriakos Aloumanis, Kostantinos Mavroudis The “depressive” face of osteoporosis and the “osteoporotic” face of depression HORMONES 2013, 12(3):350-362
  175. Rzewuska M. Ferreira M, McLachlan AJ, et.al. The efficacy of conservative treatment of osteoporotic compression fractures on acute pain relief: a systematic review with meta-analysis. Eur Spine J. 2015 Apr; 24(4):702-14. doi: 10.1007/s00586-015-3821-5
  176. Sinaki M. Yoga spinal flexion positions and vertebral compression fracture in osteopenia or osteoporosis of spine: case series. Pain Pract. 2013 Jan;13(1):68-75. doi: 10.1111/j.1533-2500.2012. 00545.x.
  177. Sran MM1, Khan KM. Physiotherapy and osteoporosis: practice behaviors and clinicians' perceptions--a survey. Man Ther. 2005 Feb;10(1):21-7.
  178. Родионова С.С. Фурцева Л.Н. Бурдыгина Н.В.Использование #альфакальцидола (альфа ДЗ ТЕВА) для лечения остеопороза Врач. - 1996. -№514-16.
  179. Ringe JD, Schacht E Improving the outcome of established therapies for osteoporosis by adding the active D-hormone analog alfacalcidol. Rheumatol Int 2007.28(2):103–111 DOI 10.1007/s00296-007-0422-6
  180. Gaál J, Bender T, Varga J et al. Overcoming resistance to bisphosphonates through the administration of alfacalcidol: results of a 1-year, open follow-up study. Rheumatol Int. 2009. 30 (1):25-31. doi: 10.1007/s00296-009-0892-9.
  181. Zhou J, Ma X, Wang T, et al. Comparative efficacy of bisphosphonates in short-term fracture prevention for primary osteoporosis: a systematic review with network meta-analyses. Osteoporos Int. 2016. 27 (11):3289-3300. DOI: 10.1007/s00198-016-3654-z
  182. Ma Z, Li Y, Zhou M, Huang K, Hu H, Liu X, Xu X. Predictors of Ibandronate Efficacy for the Management of Osteoporosis: A Meta-Regression Analysis. PLoS One. 2016 Mar 1;11(3):e0150203. doi: 10.1371/journal.pone.0150203. eCollection 2016 
  183. Aaron Broadwell, Arkadi Chines, Peter R. Ebeling, Edvard Franek et.al. Denosumab Safety and Efficacy Among Participants in the FREEDOM Extension Stady wich Mild to Moderate Chronic Kidney Diseasse. J. Clinic. Endoc Metab.2021.vol.106.2: 397-409.
  184. Cummings SR, San Martin J, McClung MR, Siris ES, Eastell R et.al. FREEDOM Trial. Collaborators. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N. Engl J Med 2009. Aug.20. 361(8):756-65. DOI: 10.1056/NEJMoa0809493
  185. Smith MR, Egerdie B, Hernández Toriz N, Feldman R, Tammela TL, et.al. Denosumab HALT Prostate Cancer Study Group. Collaborators. Denosumab in men receiving androgen-deprivation therapy for prostate cancer. N Engl. J Med. 2009 Aug 20; 361(8):745-55. DOI: 10.1056/NEJMoa0809003
  186. Nakamura T., Matsumoto T., Sugimoto T, Hosoi T, Miki T, Gorai I, et.al. Clinical Trials Express: fracture risk reduction with denosumab in Japanese postmenopausal women and men with osteoporosis: denosumab fracture intervention randomized placebo controlled trial (DIRECT). J Clin Endocrinol. Metab. 2014. Jul; 99(7):2599-607. DOI: 10.1210/jc.2013-4175
  187. McClung MR, Wagman RB, Miller PD, Wang A, Lewiecki Observations following discontinuation of long-term denosumab therapy. Osteoporos Int. 2017 May; 28(5):1723-1732. DOI: 10.1007/s00198-017-3919-1
  188. Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB,et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl. J Med. 2001 May 10. 344 (19):1434-41. DOI: 10.1056/NEJM200105103441904
  189. Jiang Y, Zhao JJ, Mitlak BH, Wang O, Genant HK, Eriksen EF .Recombinant human parathyroid hormone (1-34) [teriparatide] improves both cortical and cancellous bone structure. J Bone Miner Res. 2003 Nov; 18 (11):1932-41. DOI: 10.1359/jbmr.2003.18.11.1932
  190. Karantana A, Handoll HH, Sabouni A. Percutaneous pinning for treating distal radial fractures in adults. Cochrane Database Syst Rev. 2020 Feb 7;2(2):CD006080. doi: 10.1002/14651858.CD006080.pub3.
  191. Foldhazy Z, Ahrengart L, Leif A. External fixation versus closed treatment of displaced distal radial fractures in elderly patients: A randomized controlled trial. Current Orthopaedic Practice 2010; 21 (3):288-295.DOI : 10.1097/BCO.0b013e3181cd6513
  192. Ju JH., Jin G., Li G X., Hu HY, Hou RX. Comparison of treatment outcomes between nonsurgical and surgical treatment of distal radius fracture in elderly: a systematic review and meta-analysis. Langenbecks Arch, Surg 2015 Oct. 400 (7):767-79. DOI: 10.1007/s00423-015- 1324-9
  193. Chaudhry H, Kleinlugtenbelt Y.V., Mundi R. Cochrane Central Register of Controlled Are Volar Locking Plates Superior to Percutaneous K-wires for Distal Radius Fractures? A Meta- analysis. Clin. Orthop. Relat. Res. 2015. 473 3017–3027. DOI: 10.1007/s11999-015-4347-1
  194. Bartl C, Stengel D, Gülke J, Gebhard F. Clinical results following conservative and surgical treatment of osteoporotic distal radius fractures in the elderly: Overview of best available evidence. Unfalichrung. 2016. Sep; 119 (9):723-31. doi: 10.1007/s00113-016-0216-y.
  195. Arora R, Lutz M, Deml C, Krappinger D, Haug L, Gabl M. A prospective randomized trial comparing nonoperative treatment with volar locking plate fixation for displaced and unstable distal radial fractures in patients sixty-five years of age and older. J Bone Joint Surg Am 2011 Dec 7; 93 (23):2146-2153. DOI: 10.2106/JBJS.J.01597
  196. Aspenberg P, Genant H., Johansson T. et al. Teriparatide for acceleration of fracture repair in humans: a prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fractures. J Bone Miner Res. 2010 Feb; 25 (2):404-14. DOI: 10.1359/jbmr.090731
  197. Родионова С.С. Хакимов У.Р Обоснование использования альфакальцидола в комбинации c БФ при постменопаузальной и сенильной формах системного остеопороза. Фарматека. 2016. Спецвыпуск. « Остеопороз». 35-40.
  198. Гладкова Е.Н. Ходырев Е.Н. Лесняк О.М. Анализ состояния оказания медицинской помощи и исходов у больных с переломами проксимального отдела бедра. Остеопороз и остеопатия. 2011. 3: 7-10.
  199. Загородний Н.В. Эндопротезирование тазобедренного сустава. Основы и практика. Вестник травматологии и ортопедии им. Н. Н. Приорова. 2012. 91-92.
  200. Ершова О.Б., Белова К.Ю., Дегтярев А.А., Ганерт О.А c соавт. Анализ летальности у пациентов с переломом проксимального отдела бедренной кости Остеопороз и остеопатии. 2015. 3: 3-8.
  201. Griffiths R, Alper J Beckingsale A., et. al. Management of proximal femoral fractures. 2011: Associational Anesthetists of Great Britain and Ireland. Anesthesia. 2012 Jan; 67(1):85-98. doi: 10.1111/j.1365-2044.2011.06957x.
  202. Friedman SM, Mendelson DA, Bingham KW, Kates SL. Impact of a comanaged Geriatric Fracture Center on short-term hip fracture outcomes. Arch. Intern. Med. 2009 Oct 12;1 (18):1712-7. doi: 10.1001/archinternmed.2009.321.
  203. Friedman SM, Mendelson DA, Kates SL, McCann RM. Geriatric co-management of proximal femur fractures: total quality management and protocol-driven care result in better outcomes for a frail patient population. J Am. Geriatric Soc. 2008 Jul;56 (7):1349-56. doi: 10.1111/j.1532-5415.2008.01770.x. 
  204. F. Ferré 1 , V. Minville Preoperative management to reduce morbidity and mortality of hip fracture Ann Fr Anesth Reanim2011 Oct;30(10):e45-8. doi: 10.1016/j.annfar.2011.08.008. Epub 2011 Sep 25.
  205. Simunovic N, Devereaux PJ, Sprague S, et al. Effect of early surgery after hip fracture on mortality and complications: systematic review and meta-analysis. CMAJ. 2010 Oct 19;182 (15):1609-16. doi: 10.1503/cmaj.092220.
  206. Silverman SL, Kupperman ES, Bukata SV, Members of IOF Fracture Working Group Fracture healing: a consensus report from the International Osteoporosis FoundationFracture Working Group Osteoporos Int (2016) 27:2197–2206 DOI 10.1007/s00198- 016-3513-y
  207. Baroni M, Serra R, Boccardi V, Ercolani S, Zengarini E, Casucci P, Valecchi R, Rinonapoli G, Caraffa A, Mecocci P, Ruggiero C. The orthogeriatric comanagement improves clinical outcomes of hip fracture in older adults. Osteoporos Int. 2019 Apr;30(4):907-916. doi: 10.1007/s00198-019-04858-2. Epub 2019 Feb 4.
  208. Gdalevich M, Cohen D et al, Morbidity and mortality after hip fracture: the impact of operative delay, Arch Orthop. Trauma Surg. 2004 Jun; 124(5): 334-40. DOI: 10.1007/s00402-004- 0662-9
  209. Raaymakers E. The non-operative treatment of impacted femoral neck fractures. Injury. 2002. Dec; 33 (Supp l 3): 8-14.
  210. Oakey JW, Stover MD, Summers HD, et al. Does screw configuration affect subtrochanteric fracture after femoral neck fixation? Clin. Orthop. Relat. Res. 2006. 443: 302-306. DOI: 10.1097/01.blo.0000188557.65387.fc
  211. Han S. K., Song H. S., Kim R., Kang S. H. Clinical results of treatment of garden type 1 and 2 femoral neck fractures in patients over 70-year old .European Journal of Trauma and Emergency Surgery volume 42, pages191–196 (2016) .doi: 10.1007/s00068-015- 0528-6. Epub 2015 Apr 18.
  212. Lutnick E, Kang J, Freccero DM. Surgical Treatment of Femoral Neck Fractures: A Brief Review. Geriatrics (Basel). 2020 Apr 1;5(2):22. doi: 10.3390/geriatrics5020022.
  213. Лазарев А.Ф., Солод Э.И., Николаев А.П., Говрюшенко Н.С. Биомеханическое обоснование полифасцикулярного остеосинтеза пучками V-образных напряженных спиц. Хирургия им. Грекова, 1999г №3 С. 45-48
  214. Marek Majernícek 1, P Dungl, J Kolman, T Malkus, J Vaculík. Osteosynthesis of intracapsular femoral neck fractures by dynamic hip screw (DHS) fixation . Аcta Chir Orthop Traumatol Cech 2009 Aug;76(4):319-25
  215. Baker RP, Squires B, Gargan MF, Bannister GC. Total hip arthroplasty and hemiarthroplasty in mobile, independent patients with a displaced intracapsular fracture of the femoral neck: a randomized, controlled trial. J Bone Joint Surg. Am. 2006. 88. (12): 2583-2589. DOI: 10.2106/JBJS.E.01373
  216. Lee KB, Howe TS, Chang HC. Cancellous screw fixation for femoral neck fractures: one hundred and sixteen patients. Ann. Acad. Med. Singapore. 2004. 33 (2):248-251.
  217. Blomfeldt R, Tornkvist H, Eriksson K, et al. A randomised controlled trial comparing bipolar hemiarthroplasty with total hip replacement for displaced intracapsular fractures of the femoral neck in elderly patients. J Bone Joint Surg. Br. 2007.89. (2):160-165. DOI: 10.1302/0301- 620X.89B2.18576
  218. Parker MJ, Gurusamy K. Arthroplasties (with and without bone cement) for proximal femoral fractures in adults. Cochrane Database Syst Rev. 2006; (3):1-65. CD001706. DOI: 10.1002/14651858.CD001706.pub3
  219. Bojan AJ, Beimel C., Speitling A., et al. 3066 Consecutive Gamma Nails 12 years experience at a single centre. BMC Musculoskelet. Disord. 2010 Jun 26;11:133. doi: 10.1186/1471-2474-11-
  220. Haidukewych GJ, Israel TA, Berry DJ. Reverse obliquity fractures of the intertrochanteric region of the femur. J Bone Joint Surg. Am. 2001. 83. (5):643-650
  221. Zyto K, Ahrengart L, Sperber A, Tornkvist H. Treatment of displaced proximal humeral fractures in elderly patients J. Bone Jnt. Surg. Br.1997 May;79 (3):412-7. doi: 10.1302/0301-620x.79b3.7419
  222. Court-Brown C, Cattermole H, McQueen M. Impacted valgus fractures (B1.1) of the proximal humerus: the results of non-operative treatment. J Bone Joint Surg. Br. 2002 May;84(4):504-8
  223. Tingart M, Bathis H, Bouillon B, Tiling T. The displaced proximal humeral fracture: is there evidence for therapeutic concepts? Chirurg. 2001 72(11):1284–91.
  224. Handoll HH, Ollivere BJ, Rollins KE. Interventions for treating proximal humeral fractures in adults. Cochrane Database Syst. Rev. 2012 Dec 12;12: CD000434. doi: 10.1002/14651858.CD000434.pub3.
  225. Jia Z, Li W, Qin Y, Li H, Wang D, et.al.. Operative versus non-operative treatment for complex proximal humeral fractures: a meta-analysis of randomized controlled trials. Orthopedics. 2014 Jun;37(6): e543-51. doi: 10.3928/01477447-20140528-54.
  226. Song J-Q, Deng X-F, Wang Y-M2 Wang X-B,et .al. Operative vs. nonoperative treatment for comminuted proximal humeral fractures in elderly patients: a current meta-analysis. Acta Orthop. Traumatol. Turc. 2015. 49(4):345-53. doi: 10.3944/AOTT.2015.14.0451.
  227. Sadowski C, Riand N, Stern R, Hoffmeyer P. Fixation of fractures of the proximal humerus with the PlantTan humerus fixator plate: early experience with a new implant. J Shoulder Elbow Surg. 2003. 12:148–51. DOI: 10.1067/mse.2003.11
  228. Robinson CM, Stone OD, Murray IR. Proximal humeral fractures due to blunt trauma producing skin compromise. J Bone Joint Surg. Br. 2011. 93 (12):1632–7. DOI: 10.1302/0301-620X.93B11.27448
  229. Moda S, Chadha N, Sangwan S, et al. Open reduction and internal fixation of proximal humeral fractures and fracture dislocations. J Bone Joint Surg. Br. 1990. 72B:1050–2.
  230. British Orthopaedic Association and British Geriatrics Society. The care of patients with fragility fracture. 2007:15-50.
  231. Sebastiá-Forcada E1, Cebrián-Gómez R1, Lizaur-Utrilla A2, Gil-Guillén V3 Reverse shoulder arthroplasty versus hemiarthroplasty for acute proximal humeral fractures. A blinded, randomized, controlled, prospective study. J Shoulder Elbow Surg. 2014 Oct; 23 (10):1419-26. doi: 10.1016/j.jse.2014.06.035.
  232. Kallmes DF, Comstock BA, Heagerty PJ, Turner JA, et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures. N Engl J Med. 2009 Aug 6;361 (6):569-79. doi: 10.1056/NEJMoa0900563.
  233. Buchbinder R, Osborne R, Ebeling P, Wark J et.al. A Randomized Trial of Vertebroplasty for Painful Osteoporotic Vertebral Fractures. N Engl J Med. 2009 August 6. 361:557-568 doi.10.1056/NFJMoa 0900429
  234. Buchbinder R, Johnston RV, Rischin KJ, Homik J, Jones CA, Golmohammadi K, Kallmes DF. Percutaneous vertebroplasty for osteoporotic vertebral compression fracture. Cochrane Database Syst Rev. 2018 Apr 4;4(4):CD006349. doi: 10.1002/14651858.CD006349.pub3. Update in: Cochrane Database Syst Rev. 2018 Nov 06;11:CD006349.
  235. Clark W, Bird P, GonskiP, et.al. Safety and efficacy of vertebroplasty foracute painful osteoporotic fractures (VAPOUR): A multicentre, randomised, double-blind, placebo-controlled trial. Lancet. 2016 Oct 01; 388 ISSUE10052):1408-1416. DOI https://doi.org 10.1016/S0140- 6736(16)3134-1
  236. Bo Wang, Chang-Ping Zhao, Lian-Xin Song and Lian Zhu. Balloon kyphoplasty versus percutaneous vertebroplasty for osteoporotic vertebral compression fracture: a meta- analysis and systematic review Journal of Orthopaedic Surgery and Research (2018) 13:264 https://doi.org/10.1186/s13018-018-0952-5
  237. Chaudhry H, Kleinlugtenbelt YV, Mundi R, Ristevski B, Goslings JC, Bhandari M. Are Volar Locking Plates Superior to Percutaneous K-wires for Distal Radius Fractures? A Meta- analysis. Clin Orthop Relat Res. 2015 Sep;473(9):3017-27. doi: 10.1007/s11999-015-4347-1. Epub 2015 May 16.
  238. Costa M, Achten J, A Rangan A. et. al. Percutaneous fixation with Kirschner wires versus volar locking-plate fixation in adults with dorsally displaced fracture of distal radius: five- year follow-up of a randomized controlled trial Bone Joint J. 2019; Aug;101-B(8):978-983. doi: 10.1302/0301-620X.101B8.BJJ-2018-1285.R1
  239. National clinical guideline on the treatment of distal radial fractures. Danish Health Authority, 2016.1-87.
  240. Wiliksen JH, Frihagen F, Hellund JC, Kvernmo HD, Husby T. Volar lockingplace versus external fixation and adjuvant pin fixation in unstable distal radius fractures: a randomized, controlled study. J Hand Surg [AM] 2013 Aug: 38 (8): 1469-1476. DOI: 10.1016/j.jhsa.2013.04.039
  241. Dantuliri PK, Gillon T. Current treatment of distal radiais fractures: Arthroscopic assisted fracture reduction of distal radius fractures. Oper Tech Orthop. 2009; 19:88–95.
  242. Khanchandani P, Badio A. Functional outcome of arthroscopic assisted fixation of distal radius fractures. Indian J Orthop. 2013 May-Jun; 47(3): 288–294. doi: 10.4103/0019- 5413.109872.
  243. Walenkamp MM, Bentohami A, Beerekamp MS, Peters RW, van der HeidenR, Goslings JC, et al. Functional outcome in patients with unstable distal radius fractures, volar locking plate versus external fixation: a meta-analysis. Strategies Trauma Limb Reconstr 2013 Aug 8; (2): 67-75. DOI: 10.1007/s11751-013-0169-4
  244. Голубев В.Г., Крупаткин А.И., Зейналов В.Т и др. Новые возможности лечения комплексного регионарного болевого синдрома верхней конечности с помощью торакоскопической симпатэктомии. Вестн. РАМН. 2008. 8:. 52 – 55.
  245. Российские клинические рекомендации по профилактике и лечению ВТЭО // Флебология. 2015. Т. 9, № 4, выпуск 2. С. 4–52.
  246. Курбанов С.Х. Индивидуальная реабилитация после эндопроте-зирования тазобедренного сустава: Автореф. дис. …д-ра мед. наук. – СП б. 2009. – 38 с.;
  247. Jun-Il Yoo, Yong-Chan Ha, Jae-young Lim et al Early Rehabilitation in Elderly after Arthroplasty versus Internal Fixation for Unstable Intertrochanteric Fractures of Femur: Systematic Review and Meta-Analysis J Korean Med Sci. 2017 May; 32(5): 858–867 doi: 10.3346/jkms.2017.32.5.858
  248. Bhave A, Mont M, Tennis S, Nickey M, Starr R, and Etienne G. Functional problems and treatment solutions after total hip and knee joint arthroplasty. J Bone Joint Surg Am 87 Suppl 2: 9-21, 2005; doi:10.2106/JBJS.E.00628
  249. Hodgson SA, Mawson SJ, Stanley D. Rehabilitation after two-part fractures of the neck of the humerus. J Bone Joint Surg. Br. 2003 85B:419–22.
  250. Burke TN, Franca FJR, Ferreira de Meneses SR, Pereira RMR, Marques AP. Postural control in elderly women with osteoporosis: comparison of balance, strengthening and stretching exercises. A randomized controlled trial. Clinical Rehabilitation; 26 (11): 1021-1031. 2012. DOI: 10.1177/0269215512442204
  251. Hongo M, Miyakoshi N, Shimada Y, Sinaki M. Association of spinal curve deformity and back extensor strength in elderly women with osteoporosis in Japan and the United States. Ooros Int. 2012; 23 (3):1029–1034. DOI: 10.1007/s00198-011-1624-z
  252. Angın E, Erden Z, Can F. The effects of Clinical Pilates Exercises on bone mineral density (BMD), physical performance and quality of life of women with postmenopausal osteoporosis. J Back Musculoskelet Rehabil. 2015. 28 (4):849–858. doi: 10.3233/BMR-150604
  253. Ueda T, Higuchi Y, Imaoka M, Todo E, Kitagawa T, Ando S. Tailored education program using home floor plans for falls prevention in discharged older patients: A pilot randomized controlled trial. Arch Gerontol Geriatr. 2017; 71:9-13.
  254. Ершова О.Б., Белова К.Ю. Дегтярев А.А. с соавт. Анализ летальности у пациентов с переломом проксимального отдела бедра. Остеопороз и остеопатии 2015; №3. с3-8.
  255. Клинические рекомендации КР 614 «Патологические переломы, осложняющие течение остеопороза». 2018.
  256. Клинические рекомендации КР 600 «Падения у пациентов пожилого и старческого возраста».2020.
  257. Konstantinos I Alexiou 1, Andreas Roushias 2, Sokratis E Varitimidis 1, Konstantinos N Malizos 1 Quality of life and psychological consequences in elderly patients after a hip fracture: a review Clin Interv Aging. 2018 Jan 24;13:143-150. doi: 10.2147/CIA.S150067.
  258. Aro HT, Nazari-Farsani S, Vuopio M, Löyttyniemi E, Mattila K. Effect of Denosumab on Femoral Periprosthetic BMD and Early Femoral Stem Subsidence in Postmenopausal Women Undergoing Cementless Total Hip Arthroplasty. JBMR Plus. 2019 Aug 14;3(10):e10217. doi: 10.1002/jbm4.10217
  259. Pope D, Tang P. Carpal Tunnel Syndrome and Distal Radius Fractures. Hand Clin. 2018 Feb;34(1):27-32. doi: 10.1016/j.hcl.2017.09.003. PMID: 29169594.
  260. Niver GE, Ilyas AM. Carpal tunnel syndrome after distal radius fracture. Orthop Clin North Am. 2012 Oct;43(4):521-7. doi: 10.1016/j.ocl.2012.07.021. Epub 2012 Sep 4. PMID: 23026468.
  261. Hill JR, Navo PD, Bouz G, Azad A, Pannell W, Alluri RK, Ghiassi A. Immobilization following Distal Radius Fractures: A Randomized Clinical Trial. J Wrist Surg. 2018 Nov;7(5):409- 414. doi: 10.1055/s-0038-1667302. Epub 2018 Aug 7. PMID: 30349755; PMCID: PMC6196089
  262. Stryla W, Pogorzala AM, Rogala P, Nowakowski A. Algorithm of physical therapy exercises following total hip arthroplasty Pol Orthop Traumatol. 2013 Jan 9;78:33-9.
  263. Рудь И. М., Мельникова Е. А., Рассулова М. А., Разумов А. Н., Гореликов А. Е. Реабилитация больных после эндопротезирования суставов нижних конечностей Журнал: Вопросы курортологии, физиотерапии и лечебной физической культуры. 2017;94(6): 38-44
  264. Colón-Emeric C. S., Saag K. G. Osteoporotic fractures in older adults //Best practice & research Clinical rheumatology. – 2006. – Т. 20. – №. 4. – С. 695-706.
  265. Cicala D. et al. Atraumatic vertebral compression fractures: differential diagnosis between benign osteoporotic and malignant fractures by MRI //Musculoskeletal surgery. – 2013. – Т. 97. – №. 2. – С. 169-179.
  266. Kim D. H., Silber J. S., Albert T. J. Osteoporotic vertebral compression fractures //Instructional course lectures. – 2003. – Т. 52. – С. 541-550.
  267. O'Donnell S, Moher D, Thomas K, Hanley DA, Cranney A. Systematic review of the benefits and harms of calcitriol and alfacalcidol for fractures and falls. J Bone Miner Metab. 2008;26(6):531-42. doi: 10.1007/s00774-008-0868-y.
  268. Shi L. et al. Bisphosphonates for secondary prevention of osteoporotic fractures: a bayesian network meta-analysis of randomized controlled trials //BioMed research international. – 2019. – Т. 2019.
  269. Wen F. et al. Clinical efficacy and safety of drug interventions for primary and secondary prevention of osteoporotic fractures in postmenopausal women: Network meta-analysis followed by factor and cluster analysis //PloS one. – 2020. – Т. 15. – №. 6. – С. e0234123.
  270. Shiga T, Wajima Z, Ohe Y. Is operative delay associated with increased mortality of hip fracture patients? Systematic review, meta-analysis, and meta-regression. Can J Anaesth. 2008 Mar;55(3):146-54. doi: 10.1007/BF03016088.
  271. Khan SK, Kalra S, Khanna A, Thiruvengada MM, Parker MJ. Timing of surgery for hip fractures: a systematic review of 52 published studies involving 291,413 patients. Injury. 2009 Jul;40(7):692-7. doi: 10.1016/j.injury.2009.01.010.
  272. Adler R. A. Duration of anti-resorptive therapy for osteoporosis //Endocrine. – 2016. – Vol. 51. – №. 2. – P. 222-224.
  273. Dennison E. M. et al. Fracture risk following intermission of osteoporosis therapy //Osteoporosis International. – 2019. – Vol. 30. – №. 9. – P. 1733-1743.
  274. Zhu R. S. et al. Which is the best treatment of osteoporotic vertebral compression fractures: ballo on kyphoplasty, percutaneous vertebroplasty, or non-surgical treatment? A Bayesian network meta-analysis //Osteoporosis International. – 2019. – Vol. 30. – №. 2. – P. 287-298.

Для продолжения работы требуется Registration
На предыдущую страницу

Предыдущая страница

Следующая страница

На следующую страницу
Список литературы
На предыдущую главу Предыдущая глава
оглавление
Следующая глава На следующую главу